Houston-based Medical device company Procyrion, Inc., recently made a significant personnel move to promote one of the company’s executives to its board of directors. Last week, Steven Oldham was appointed to the board, and will represent Procyrion’s Series A stockholders while also assisting the management team in further executing the company’s efforts to commercialize Aortix™, a medical device that the company claims is the first-of-its-kind “catheter-deployed circulatory assist device” that patients can use for long-term treatment in protecting against chronic heart failure.